Which of the following is the most appropriate initial nursing intervention for a patient suspected of having pulmonary tuberculosis?

A) Initiate airborne isolation precautions

C) Provide oxygen therapy at 2 L/min via nasal cannula

D) Encourage high-calorie dietary intake

What is the primary reason for instructing a patient with pulmonary tuberculosis to adhere strictly to the prescribed medication regimen?

B) To prevent the development of drug-resistant strains of tuberculosis

A) To promote rapid weight gain

B) To prevent the development of drug-resistant strains of tuberculosis

C) To ensure the patient's comfort and pain relief

D) To avoid the need for surgical intervention

When monitoring a patient on an anti-tuberculosis regimen, which of the following findings would require immediate intervention?

D) Severe abdominal pain and jaundice

A) Mild fatigue and occasional nausea

B) Stable vital signs with mild elevation in liver enzymes

C) Patient reports adherence to infection control measures

D) Severe abdominal pain and jaundice

Which of the following is the most important nursing intervention when a patient on anti-tuberculosis medication presents with mildly elevated liver enzymes?

C) Instruct the patient to avoid alcohol and hepatotoxic substances

A) Encourage increased protein intake

B) Advise the patient to stop all medications immediately

C) Instruct the patient to avoid alcohol and hepatotoxic substances

D) Increase the frequency of liver function tests to weekly

A patient undergoing treatment with anti-tuberculosis medication presents with mild right upper quadrant discomfort and slightly elevated liver enzymes. What is the most appropriate nursing action based on these findings?

B) Schedule more frequent liver function tests and monitor for worsening symptoms.

A) Advise the patient to stop all medications immediately.

B) Schedule more frequent liver function tests and monitor for worsening symptoms.

C) Suggest the patient increase their dietary intake of protein.

D) Recommend the patient start a new exercise regimen to alleviate discomfort.

When monitoring a patient on anti-tuberculosis medication with slightly elevated liver enzymes, which of the following is the most important action for the nurse to take?

B) Educate the patient on signs of liver dysfunction

A) Advise the patient to increase their fluid intake

B) Educate the patient on signs of liver dysfunction

C) Suggest the patient stop the medication immediately

D) Recommend the patient start a low-fat diet

Tuberculosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Tuberculosis (TB) is caused by the bacterium Mycobacterium tuberculosis, which primarily infects the lungs. It enters the body through inhaled droplets and initially infects alveolar macrophages, leading to an immune response.

• Secondary mechanism: The immune system forms granulomas, which are clusters of immune cells that attempt to contain the bacteria. This can result in the bacteria becoming dormant and the person being in a latent TB state, which can reactivate if the immune system weakens.

• Key complication: If the granulomas fail to contain the infection, the bacteria can spread, causing active TB disease. This leads to symptoms like a persistent cough, chest pain, and weight loss, and can cause damage to lung tissue, potentially spreading to other organs.

Patient Profile

Demographics:

32-year-old male, office worker

History:

• Key past medical history: No significant past medical history

• Current medications: None

• Allergies: No known drug allergies

Current Presentation:

• Chief complaint: Persistent cough for 3 weeks

• Key symptoms: Low-grade fever, night sweats, mild fatigue, weight loss

• Vital signs: Temperature 37.5°C, Heart rate 78 bpm, Blood pressure 120/80 mmHg, Respiratory rate 18 breaths per minute, Oxygen saturation 98% on room air

Section 1

Initial Assessment Findings:

Upon conducting a thorough initial nursing assessment, the patient, a 32-year-old male, presents with symptoms consistent with early-stage pulmonary tuberculosis. The patient reports a persistent cough that has lasted for three weeks, accompanied by low-grade fever, night sweats, mild fatigue, and some unintentional weight loss. Despite these symptoms, he remains relatively stable with vital signs showing a slightly elevated temperature of 37.5°C, a heart rate of 78 bpm, blood pressure of 120/80 mmHg, a respiratory rate of 18 breaths per minute, and an oxygen saturation of 98% on room air. During the physical examination, auscultation of the lungs reveals bilateral crackles, particularly noticeable in the upper lobes, which is typical for TB infection. No significant lymphadenopathy is detected, and the patient has no signs of respiratory distress.

The nurse notes the patient’s overall good nutritional status and normal body mass index, despite the reported weight loss. A Mantoux tuberculin skin test is administered, and a chest X-ray is ordered to further evaluate the extent of lung involvement. The nurse educates the patient about the importance of adherence to follow-up appointments and anticipates the initiation of a standard anti-tuberculosis treatment regimen pending confirmation of diagnosis. Additionally, the nurse emphasizes the importance of infection control measures, such as wearing a mask and practicing good cough etiquette, to minimize the risk of transmission to others. The patient expresses understanding and a willingness to comply with the recommended precautions and treatment plan.

These initial findings provide a foundation for developing an appropriate care plan, focusing on monitoring the patient's respiratory status and response to treatment. The next steps involve waiting for diagnostic results, including the chest X-ray and Mantoux test, to confirm the diagnosis and guide the initiation of a specific treatment regimen. This early intervention is critical to prevent the progression of the disease and ensure the patient's recovery while minimizing the risk of spreading the infection to others.

Section 2

New Diagnostic Results:

The follow-up diagnostic results have returned, providing further clarity on the patient's condition. The Mantoux tuberculin skin test shows an induration of 15 millimeters, which is considered positive and indicative of exposure to Mycobacterium tuberculosis. The chest X-ray reveals infiltrates in the upper lobes of the lungs, consistent with early-stage pulmonary tuberculosis. No cavities or significant lung damage are observed, suggesting that the disease is in its initial stages. Sputum cultures have been sent for analysis, but the results are still pending. These findings confirm the preliminary diagnosis of pulmonary tuberculosis, enabling the healthcare team to initiate a tailored treatment plan.

With the confirmation of tuberculosis, the patient is started on a first-line anti-tuberculosis regimen, typically including isoniazid, rifampin, pyrazinamide, and ethambutol. The nurse explains the importance of adhering to the medication schedule to prevent drug resistance and ensure effective treatment. The patient is also educated about potential side effects of the medications, such as liver toxicity and visual disturbances, and is advised to report any unusual symptoms promptly. Regular monitoring of liver function tests and visual acuity is planned as part of ongoing care.

As the treatment begins, the nursing team continues to monitor the patient's response closely. The patient is encouraged to maintain good nutrition and hydration to support recovery. Infection control measures are reinforced, with the patient advised to continue wearing a mask in public and practicing good hand hygiene. The patient expresses a positive outlook and a strong commitment to following the treatment protocol, which is crucial for a favorable outcome. The care team schedules regular follow-ups to assess progress, adjust the treatment plan as needed, and address any new concerns that may arise during the course of therapy.

Section 3

As the treatment progresses, the healthcare team closely monitors the patient's response to the anti-tuberculosis regimen. During one of the follow-up appointments, the patient reports mild fatigue and occasional nausea, common side effects of the medications. Upon conducting a thorough assessment, the nurse notes that the patient's vital signs remain stable: blood pressure is 118/76 mmHg, heart rate is 78 beats per minute, respiratory rate is 18 breaths per minute, and temperature is 98.6°F (37°C). The patient has maintained a healthy weight and reports a balanced diet, suggesting good nutritional support.

The nurse reviews the results of the recent liver function tests, which show mildly elevated liver enzymes, indicating a mild hepatic response to the medication but not severe enough to warrant immediate changes to the regimen. The nursing team emphasizes the importance of continuing to monitor these values and instructs the patient to avoid alcohol and other hepatotoxic substances to protect liver health. Additionally, the results of the sputum cultures have returned, confirming the presence of Mycobacterium tuberculosis, which supports the continuation of the current treatment plan.

The patient also reports that they have been adhering to infection control measures diligently, wearing a mask when necessary and practicing good hand hygiene. This adherence is crucial in preventing the spread of the infection to others. The care team acknowledges the patient’s commitment and encourages continued compliance with both medication and lifestyle modifications. With ongoing support and regular monitoring, the patient is optimistic about recovery and is scheduled for the next follow-up to evaluate further progress and address any emerging issues.

Section 4

A few weeks later, during another routine follow-up appointment, the patient presents with a slight increase in fatigue and a new complaint of mild right upper quadrant discomfort. The nurse conducts another comprehensive assessment, noting that the patient's vital signs remain stable: blood pressure is 120/78 mmHg, heart rate is 80 beats per minute, respiratory rate is 19 breaths per minute, and temperature is 98.7°F (37.1°C). Despite the new symptom, the patient continues to maintain a healthy weight and reports adhering to a balanced diet.

The nurse reviews the latest laboratory results, which reveal that liver enzyme levels have increased slightly from the previous check, but still remain within the acceptable range. Notably, the patient’s alkaline phosphatase levels have also shown a mild elevation. These findings suggest a need for cautious monitoring but do not yet necessitate an immediate change in the anti-tuberculosis regimen. The nurse reinforces the importance of avoiding alcohol and other hepatotoxic substances, and advises the patient to report any worsening symptoms such as jaundice or significant abdominal pain.

In light of these developments, the healthcare team decides to schedule more frequent liver function tests to ensure that any potential hepatotoxicity is identified early. The patient is reassured that these are precautionary measures and is encouraged to continue with the current treatment plan while maintaining strict adherence to infection control measures. The team remains optimistic about the patient's recovery and emphasizes the importance of open communication regarding any changes in symptoms. The next follow-up is scheduled to reassess both the clinical symptoms and laboratory findings, with a focus on adjusting the treatment plan if necessary.

Section 5

At the next follow-up appointment, the patient reports feeling slightly more energetic but mentions occasional episodes of light dizziness, particularly when standing up quickly. The nurse conducts a thorough assessment and notes that the patient's vital signs remain stable: blood pressure is 118/76 mmHg, heart rate is 82 beats per minute, respiratory rate is 18 breaths per minute, and temperature is 98.6°F (37°C). The mild right upper quadrant discomfort persists, but the patient denies any new or worsening symptoms such as jaundice or significant abdominal pain. The patient's weight remains consistent with previous measurements, indicating continued adherence to a balanced diet.

The latest laboratory results show a slight improvement in liver enzyme levels, with ALT and AST returning closer to baseline values, though alkaline phosphatase remains mildly elevated. These results suggest a positive response to the current monitoring and avoidance of hepatotoxic substances. The healthcare team acknowledges the importance of maintaining the current anti-tuberculosis regimen while keeping a close eye on liver function. The nurse emphasizes the need for the patient to continue avoiding alcohol and to report any new symptoms promptly.

Given the patient's stable condition and slight improvement in symptoms, the healthcare team decides to maintain the current treatment plan but will continue with the previously scheduled frequent liver function tests. The team advises the patient to remain vigilant in following infection control measures and to maintain open communication about any changes in their condition. The next follow-up is planned to reassess the patient's clinical status and laboratory findings, ensuring that any necessary adjustments can be made in a timely manner. The patient leaves the clinic feeling reassured and supported by their healthcare team.